Vertex Pharmaceuticals Incorporated carries a market capitalization of 108.96B, placing it among publicly traded companies globally.
| Market Cap | 108.96B |
| Enterprise Value | N/A |
Vertex Pharmaceuticals Incorporated's stock has declined approximately -4.79827% over the past 52 weeks. The 50-day moving average sits at 424.38, while the 200-day moving average is 373.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | -4.79827% |
| 50-Day Moving Average | 424.38 |
| 200-Day Moving Average | 373.25 |
| Average Volume (20 Days) | N/A |